Dr Peter E. Penson – Kudos: Growing the influence of research

All Stories

Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies

Article • European Journal of Preventive Cardiology, April 2023, Oxford University Press (OUP)

Dr Peter E. Penson
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

Article • Pharmacological Research, March 2023, Elsevier

Dr Peter E. Penson, Dr. med. Sonu Bhaskar
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

Article • Progress in Cardiovascular Diseases, March 2023, Elsevier

Dr Peter E. Penson
Which Statin is Best for the Kidneys?

Article • Current Vascular Pharmacology, January 2023, Bentham Science Publishers

Dr Peter E. Penson, Prof. Maciej Banach
Abstracts of the 18th Congress of the European Geriatric Medicine Society

Article • European Geriatric Medicine, December 2022, Springer Science + Business Media

Dr Peter E. Penson
Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018

Article • Age and Ageing, December 2022, Oxford University Press (OUP)

Dr Peter E. Penson
Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

Article • Cardiovascular Diabetology, November 2022, Springer Science + Business Media

Dr Peter E. Penson
Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study

Article • British Journal of General Practice, November 2022, Royal College of General Practitioners

Dr Peter E. Penson
2022: The Year in Cardiovascular Disease – The Year of Upfront Lipid Lowering Combination Therapy.

Article • Archives of Medical Science, October 2022, Termedia Sp. z.o.o.

Dr Peter E. Penson
Adherence to statin therapy - it seems we know everything, yet we do nothing…

Article • European Heart Journal Open, October 2022, Oxford University Press (OUP)

Dr Peter E. Penson
Individualized therapy in statin intolerance: the key to success

Article • European Heart Journal, October 2022, Oxford University Press (OUP)

Dr Peter E. Penson
Factors associated with prescription of oral anticoagulation for atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018

Article • European Heart Journal, October 2022, Oxford University Press (OUP)

Dr Peter E. Penson
Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018

Article • European Heart Journal, October 2022, Oxford University Press (OUP)

Dr Peter E. Penson
Selected Abstracts from Pharmacology 2022

Article • British Journal of Clinical Pharmacology, September 2022, Wiley

Dr Peter E. Penson
Risk factors for post sternotomy wound complications across the patient journey: A systematised review of the literature

Article • Heart & Lung, September 2022, Elsevier

Dr Peter E. Penson
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel

Article • Pharmacological Research, September 2022, Elsevier

Dr Peter E. Penson
P17-04 An automated tool for selection of chemical analogues to facilitate development of new physiologically-based kinetic models using a read-across approach

Article • Toxicology Letters, September 2022, Elsevier

Dr Peter E. Penson
Integrated care for atrial fibrillation management: The role of the pharmacist

Article • The American Journal of Medicine, August 2022, Elsevier

Dr Peter E. Penson
1300 Transfer of outpatient paediatric prescriptions to primary care via the Electronic Prescription Service (EPS)- community pharmacist views

Article • August 2022, BMJ

Dr Peter E. Penson
Identifying and addressing pill aversion in adults without physiological‐related dysphagia: A narrative review

Article • British Journal of Clinical Pharmacology, July 2022, Wiley

Dr Peter E. Penson
Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?

Article • Frontiers in Nutrition, May 2022, Frontiers

Dr Peter E. Penson
Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol

Article • Journal of Personalized Medicine, April 2022, MDPI AG

Lis Neubeck, Dr Peter E. Penson
Lifetime serum concentration of 25-hydroxyvitamin D 25(OH) is associated with hand grip strengths: insight from a Mendelian randomisation

Article • Age and Ageing, April 2022, Oxford University Press (OUP)

Dr Peter E. Penson
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

Article • Journal of Cachexia Sarcopenia and Muscle, March 2022, Wiley

Dr Peter E. Penson, Dr. med. Sonu Bhaskar
Prevalence of statin intolerance: a meta-analysis

Article • European Heart Journal, February 2022, Oxford University Press (OUP)

Dr Peter E. Penson
Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly condition

Article • European Journal of Preventive Cardiology, February 2022, Oxford University Press (OUP)

Dr Peter E. Penson, Prof. Maciej Banach
Warfarin—Is Self-Care the Best Care?

Article • Thrombosis and Haemostasis, February 2022, Thieme Publishing Group

Dr Peter E. Penson
Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress

Article • Biomarker Insights, January 2022, SAGE Publications

Dr Peter E. Penson
Stop and Go: Barriers and Facilitators to Care Home Research

Article • Journal of Frailty & Aging, January 2022, SERDI

Dr Peter E. Penson
Long-COVID-19: Definition, Epidemiology, and Clinical Implications

Article • January 2022, Springer Science + Business Media

Dr Peter E. Penson
CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities

Article • Metabolites, December 2021, MDPI AG

Dr Peter E. Penson
Potential Benefits of Phytochemicals for Abdominal Aortic Aneurysm

Article • Current Medicinal Chemistry, December 2021, Bentham Science Publishers

Dr Peter E. Penson
The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study

Article • Journal of Clinical Medicine, November 2021, MDPI AG

Dr Peter E. Penson
A Systematic Review of Published Physiologically based Kinetic Models and an Assessment of their Chemical Space Coverage

Article • Alternatives to Laboratory Animals, November 2021, SAGE Publications

Dr Peter E. Penson
Extreme cardiovascular risk—do we need a new risk category?

Article • European Heart Journal, November 2021, Oxford University Press (OUP)

Dr Peter E. Penson, Prof. Maciej Banach
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study

Article • Rheumatology International, November 2021, Springer Science + Business Media

Dr Peter E. Penson, Prof. Maciej Banach
The management of asthma in adult patients in the community pharmacy setting: Literature review

Article • Research in Social and Administrative Pharmacy, November 2021, Elsevier

Dr Peter E. Penson
Associations between serum triglycerides and abdominal aortic calcification in a cross-sectional study from the United States of America

Article • European Heart Journal, October 2021, Oxford University Press (OUP)

Dr Peter E. Penson
Association between ankle-brachial index and cardiovascular mortality in a cohort from the United States of America

Article • European Heart Journal, October 2021, Oxford University Press (OUP)

Dr Peter E. Penson
The prevalence of statin intolerance worldwide: a systematic review and meta-analysis with 4,143,517 patients

Article • European Heart Journal, October 2021, Oxford University Press (OUP)

Dr Peter E. Penson
Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study

Article • Journal of Clinical Medicine, September 2021, MDPI AG

Dr Peter E. Penson, Prof. Maciej Banach
Clinical Features of Familial Hypercholesterolemia in Children and Adults in EAS-FHSC Regional Center for Rare Diseases in Poland

Article • Journal of Clinical Medicine, September 2021, MDPI AG

Dr Peter E. Penson, Prof. Maciej Banach
Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective

Article • Metabolites, September 2021, MDPI AG

Dr Peter E. Penson
Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta‐analysis of randomized controlled trials

Article • British Journal of Clinical Pharmacology, September 2021, Wiley

Dr Peter E. Penson
RNA Silencing in the Management of Dyslipidemias

Article • Current Atherosclerosis Reports, September 2021, Springer Science + Business Media

Dr Peter E. Penson
Bacterial lipopolysaccharide–Stoking the fire of residual risk?

Article • Trends in Cardiovascular Medicine, September 2021, Elsevier

Dr Peter E. Penson
Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry

Article • Atherosclerosis, September 2021, Elsevier

Dr Peter E. Penson, Prof. Maciej Banach
The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis

Article • Seminars in Cancer Biology, September 2021, Elsevier

Dr Peter E. Penson, Prof. Maciej Banach
Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice

Article • Nutrients, August 2021, MDPI AG

Prof. Maciej Banach, Dr Peter E. Penson
Statins as anti-pyroptotic agents

Article • Archives of Medical Science, August 2021, Termedia Sp. z.o.o.

Dr Peter E. Penson
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia

Article • Archives of Medical Science, July 2021, Termedia Sp. z.o.o.

Dr Peter E. Penson
Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors - analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.

Article • Archives of Medical Science, July 2021, Termedia Sp. z.o.o.

Dr Peter E. Penson, Prof. Maciej Banach
Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations

Article • European Heart Journal, June 2021, Oxford University Press (OUP)

Dr Peter E. Penson, Prof. Maciej Banach
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

Article • Progress in Cardiovascular Diseases, June 2021, Elsevier

Dr. med. Sonu Bhaskar, Dr Peter E. Penson
Assessment of asthma management in adult patients: A retrospective case-note review in a general practice

Article • British Journal of Pharmacy, May 2021, University of Huddersfield Press

Dr Peter E. Penson
Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies

Article • Current Atherosclerosis Reports, May 2021, Springer Science + Business Media

Dr Peter E. Penson
Exploring pharmacists’ views surrounding conscientious objection to abortion and implications in practice

Article • International Journal of Pharmacy Practice, April 2021, Oxford University Press (OUP)

Dr Peter E. Penson
Prevalence of anti-nuclear autoantibodies (ANA) in the general Polish population - analysis of the influence of sex and age on the variability of ANA.

Article • April 2021, Research Square

Dr Peter E. Penson
Effects of statins on myocarditis: A review of underlying molecular mechanisms

Article • Progress in Cardiovascular Diseases, February 2021, Elsevier

Dr Peter E. Penson
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

Article • Pharmacological Research, February 2021, Elsevier

Dr Peter E. Penson
Drucebo effect – the challenge we should all definitely face!

Article • Archives of Medical Science, January 2021, Termedia Sp. z.o.o.

Dr Peter E. Penson, Prof. Maciej Banach
Lipid-lowering therapies: Better together

Article • Atherosclerosis, January 2021, Elsevier

Dr Peter E. Penson, Prof. Maciej Banach
OUP accepted manuscript

Article • European Journal of Preventive Cardiology, January 2021, Oxford University Press (OUP)

Dr Peter E. Penson
Recent advancements in liposome-based strategies for effective drug delivery to the brain

Article • Current Medicinal Chemistry, December 2020, Bentham Science Publishers

Dr Peter E. Penson
Management of Statin Intolerance

Article • December 2020, Springer Science + Business Media

Dr Peter E. Penson
Statins, COVID-19, and coronary artery disease: killing two birds with one stone

Article • Metabolism, December 2020, Elsevier

Dr Peter E. Penson
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors

Article • Progress in Cardiovascular Diseases, December 2020, Elsevier

Dr Peter E. Penson
Statins and LDL-C in Secondary Prevention—So Much Progress, So Far to Go

Article • JAMA Network Open, November 2020, American Medical Association (AMA)

Dr Peter E. Penson
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes

Article • Atherosclerosis, November 2020, Elsevier

Dr Peter E. Penson
Comparison of LDL-C calculation by friedewald and martin/hopkins methods in 12,243 adults from the United States of America

Article • European Heart Journal, November 2020, Oxford University Press (OUP)

Dr Peter E. Penson
LDL-C: lower is better for longer—even at low risk

Article • BMC Medicine, October 2020, Springer Science + Business Media

Dr Peter E. Penson
Pharmacist implementation of a treatment pathway for atrial fibrillation in care home residents

Article • October 2020, Springer Science + Business Media

Dr Peter E. Penson
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia

Article • Current Atherosclerosis Reports, September 2020, Springer Science + Business Media

Dr Peter E. Penson
Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic

Article • Pharmacological Research, August 2020, Elsevier

Prof. Maciej Banach, Dr Peter E. Penson
Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis

Article • PLoS Medicine, July 2020, PLOS

Dr Peter E. Penson, Dr Arrigo FG CICERO, Prof. Maciej Banach
Epigenetic control of atherosclerosis via DNA methylation: A new therapeutic target?

Article • Life Sciences, July 2020, Elsevier

Dr Peter E. Penson
Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice

Article • Future Cardiology, May 2020, Future Medicine

Dr Peter E. Penson
What's new in lipid‐lowering pharmacology? Integrating basic and clinical research to improve patient outcomes

Article • British Journal of Clinical Pharmacology, May 2020, Wiley

Dr Peter E. Penson
Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP)

Article • Pharmacological Research, May 2020, Elsevier

Dr Peter E. Penson
What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?

Article • Progress in Cardiovascular Diseases, May 2020, Elsevier

Dr Peter E. Penson
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

Article • Clinical Nutrition, May 2020, Elsevier

Dr Peter E. Penson
Liposome Circulation Time is Prolonged by CD47 Coating

Article • Protein and Peptide Letters, April 2020, Bentham Science Publishers

Dr Peter E. Penson
Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in Bahrain

Article • Foods, April 2020, MDPI AG

Dr Peter E. Penson
Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants

Article • Clinical Nutrition, April 2020, Elsevier

Dr Peter E. Penson
Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection

Article • Expert Opinion on Drug Delivery, March 2020, Taylor & Francis

Dr Peter E. Penson
Vitamin D and SAMS

Article • January 2020, Springer Science + Business Media

Dr Peter E. Penson
Inclisiran—New hope in the management of lipid disorders?

Article • Journal of Clinical Lipidology, January 2020, Elsevier

Dr Peter E. Penson
Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications

Article • Journal of Clinical Medicine, November 2019, MDPI AG

Dr Peter E. Penson
Statins and Lp(a): do not make perfect the enemy of excellent

Article • European Heart Journal, November 2019, Oxford University Press (OUP)

Dr Peter E. Penson, Prof. Maciej Banach
The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis

Article • Journal of Clinical Medicine, November 2019, MDPI AG

Dr Peter E. Penson
P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel

Article • European Heart Journal, October 2019, Oxford University Press (OUP)

Dr Peter E. Penson
Warfarin Therapy and Improved Anticoagulation Control by Patient Self-Management

Article • Thrombosis and Haemostasis, September 2019, Thieme Publishing Group

Dr Peter E. Penson
A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome

Article • Drug Discovery Today, September 2019, Elsevier

Dr Peter E. Penson, Prof. Maciej Banach
Regulatory T cells: possible mediators for the anti-inflammatory action of statins

Article • Pharmacological Research, September 2019, Elsevier

Dr Peter E. Penson
Genetic testing in familial hypercholesterolaemia: What does it add?

Article • European Journal of Preventive Cardiology, August 2019, SAGE Publications

Prof. Maciej Banach, Dr Peter E. Penson
Poster Abstracts

Article • International Journal of Pharmacy Practice, April 2019, Wiley

Dr Peter E. Penson
Worldwide Dyslipidemia Guidelines

Article • Current Cardiovascular Risk Reports, January 2019, Springer Science + Business Media

Dr Peter E. Penson
What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcomes trials?

Article • Cardiovascular Research, January 2019, Oxford University Press (OUP)

Prof. Maciej Banach, Dr Peter E. Penson
Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study

Article • Archives of Medical Science, January 2019, Termedia Sp. z.o.o.

Dr Peter E. Penson
Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis

Article • Nutrition Reviews, December 2018, Oxford University Press (OUP)

Dr Peter E. Penson
Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions

Article • Journal of Cachexia Sarcopenia and Muscle, October 2018, Wiley

Prof. Maciej Banach, Dr Peter E. Penson
Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?

Article • Expert Opinion on Pharmacotherapy, October 2018, Taylor & Francis

Prof. Maciej Banach, Professor Maciej Banach, Dr Peter E. Penson
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

Article • European Heart Journal, August 2018, Oxford University Press (OUP)

Dr Peter E. Penson, Prof. Maciej Banach
Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study

Article • Cardiovascular Research, August 2018, Oxford University Press (OUP)

Dr Peter E. Penson, Prof. Maciej Banach
P3836The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis

Article • European Heart Journal, August 2018, Oxford University Press (OUP)

Dr Peter E. Penson
P5086Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

Article • European Heart Journal, August 2018, Oxford University Press (OUP)

Dr Peter E. Penson
Lipoprotein(a) and the risk of atrial fibrillation – is there a link

Article • Heart Beat Journal, December 2017, Fundacja Heart Beat

Dr Peter E. Penson
The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis

Article • Journal of Clinical Lipidology, November 2017, Elsevier

Prof. Maciej Banach, Dr Peter E. Penson
The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis

Article • Atherosclerosis, October 2017, Elsevier

Prof. Maciej Banach, Dr Peter E. Penson
Autonomic and Autacoid Pharmacology: Goodbye and thank you

Article • Autonomic and Autacoid Pharmacology, September 2017, Wiley

Dr Peter E. Penson
Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review

Article • Critical Reviews in Food Science and Nutrition, August 2017, Taylor & Francis

Prof. Maciej Banach, Dr Peter E. Penson
The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trials

Article • Pharmacological Research, August 2017, Elsevier

Prof. Maciej Banach, Dr Peter E. Penson
3100Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis

Article • European Heart Journal, August 2017, Oxford University Press (OUP)

Dr Peter E. Penson
3104Associations between cardiovascular disease, cancer and very low hdl cholesterol in the reasons for geographical and racial differences in stroke (REGARDS) study

Article • European Heart Journal, August 2017, Oxford University Press (OUP)

Dr Peter E. Penson
P627Associations between very low concentrations of LDL-cholesterol and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) Study

Article • European Heart Journal, August 2017, Oxford University Press (OUP)

Dr Peter E. Penson
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis

Article • Journal of Clinical Lipidology, July 2017, Elsevier

Dr Peter E. Penson, Prof. Maciej Banach
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis

Article • Drugs, June 2017, Springer Science + Business Media

Prof. Maciej Banach, Dr Peter E. Penson
220 Daphnia magna as a model for quantifying chaos in cardiac arrhythmia

Article • Heart, June 2017, BMJ

Dr Peter E. Penson
Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease

Article • Journal of Clinical Lipidology, May 2017, Elsevier

Prof. Maciej Banach, Dr Peter E. Penson
The role of nutraceuticals in the prevention of cardiovascular disease

Article • Cardiovascular Diagnosis and Therapy, April 2017, AME Publishing Company

Prof. Maciej Banach, Dr Peter E. Penson
Evaluating bempedoic acid for the treatment of hyperlipidaemia

Article • Expert Opinion on Investigational Drugs, January 2017, Taylor & Francis

Prof. Maciej Banach, Dr Peter E. Penson
Association between telomere length and complete blood count in US adults

Article • Archives of Medical Science, January 2017, Termedia Sp. z.o.o.

Prof. Maciej Banach, Dr Peter E. Penson
D-003 (Saccharum officinarum): The forgotten lipid-lowering agent

Article • Pharmacological Research, December 2016, Elsevier

Prof. Maciej Banach, Dr Peter E. Penson
Effects of pentoxifylline on inflammatory markers and blood pressure

Article • Journal of Hypertension, December 2016, Wolters Kluwer Health

Prof. Maciej Banach, Dr Peter E. Penson
Sunday 28 August 2016

Article • European Heart Journal, August 2016, European Society of Cardiology

Dr Peter E. Penson
Monday 29 August 2016

Article • European Heart Journal, August 2016, European Society of Cardiology

Dr Peter E. Penson
Tuesday 30 August 2016

Article • European Heart Journal, August 2016, European Society of Cardiology

Dr Peter E. Penson
Bioresorbable scaffold — A magic bullet for the treatment of coronary artery disease?

Article • International Journal of Cardiology, July 2016, Elsevier

Prof. Maciej Banach, Dr Peter E. Penson
Autonomic & Autacoid Pharmacology 2016: The year in review

Article • Autonomic and Autacoid Pharmacology, July 2016, Wiley

Dr Peter E. Penson
Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questions

Article • Critical Reviews in Clinical Laboratory Sciences, June 2016, Taylor & Francis

Prof. Maciej Banach, Dr Peter E. Penson
Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials

Article • Pharmacological Research, May 2016, Elsevier

Prof. Maciej Banach, Dr Peter E. Penson
Autonomic & Autacoid Pharmacology: past, present and future

Article • Autonomic and Autacoid Pharmacology, December 2015, Wiley

Dr Peter E. Penson
Developing skills to deliver alcohol screening and brief intervention (SBI) in community pharmacy

Article • Addiction Science & Clinical Practice, September 2013, Springer Science + Business Media

Dr Peter E. Penson
Lecturing: A lost art

Article • Currents in Pharmacy Teaching and Learning, January 2012, Elsevier

Dr Peter E. Penson
ChemInform Abstract: Synthesis of Antagonists of Muscarinic (M3) Receptors.

Article • ChemInform, September 2011, Wiley

Dr Peter E. Penson
Synthesis of antagonists of muscarinic (M3) receptors

Article • Collection of Czechoslovak Chemical Communications, January 2011, Institute of Organic Chemistry & Biochemistry

Dr Peter E. Penson
Incense – A problematic method of drug-delivery

Article • Medical Hypotheses, April 2009, Elsevier

Dr Peter E. Penson
Activation of β-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction

Article • Naunyn-Schmiedeberg s Archives of Pharmacology, July 2008, Springer Science + Business Media

Dr Emma J Kidd, Dr Peter E. Penson
Protective role of β2- and β3-adrenoceptors at reperfusion in isolated rat heart

Article • Journal of Molecular and Cellular Cardiology, April 2008, Elsevier

Dr Peter E. Penson, Dr Emma J Kidd
Vasopressors for cardiopulmonary resuscitation

Article • Pharmacology & Therapeutics, July 2007, Elsevier

Dr Peter E. Penson
Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties

Article • European Journal of Pharmacology, May 2006, Elsevier

Dr Peter E. Penson
The roles of alpha- and beta-adrenoceptor stimulation in myocardial ischaemia

Article • Autonomic and Autacoid Pharmacology, October 2004, Wiley

Dr Peter E. Penson